The global demand for Neurology Digital Therapeutics Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Neurology digital therapeutics is a branch of medicine that uses information and communication technologies to treat and prevent medical disorders. These technologies can also be used for therapy and rehabilitation using smartphones, tablets, and PCs. Additionally, digital neurological treatments can address several issues associated with traditional clinical approaches. Neurology digital therapeutics saves time on administrative work and routine communication, decreases pain associated with conventional therapeutic methods, and makes monitoring more accessible and accurate.
Market Dynamics
The improvement of technology in the healthcare sector will be responsible for the enormous growth of digital neurology therapeutics. The increased frequency of incurable diseases, increasing order on healthcare providers to decrease healthcare costs and increasing the number of partnerships and collaborations in the industry contribute to the market's growth. The need for digital neurology therapeutics will rise because of the expanding incidence of chronic diseases among patients and the growing senior population. Additionally, as the global frequency of persistent conditions develops, opportunities for healthcare and digital treatment providers to participate in the market by inventing and offering technologically sophisticated solutions to meet the growing demand for digital neurological therapeutics are arising, boosting the overall market growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of neurology digital therapeutics. The growth and trends of neurology digital therapeutics industry provide a holistic approach to this study.
Market Segmentation
This section of the neurology digital therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
By Indication
- Diabetes
- Obesity
- Cardiovascular Disease (CVD)
- Central Nervous System (CNS) Disease
- Respiratory Disease
- Others
By End User
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Neurology Digital Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Neurology Digital Therapeutics Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the neurology digital therapeutics market include Livongo Health, Noom, Omada Health, Pear Therapeutics, WellDoc, Proteus Digital Health, Propeller Health, Akili Interactive Labs, Mango Health. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.